Retension Pharmaceuticals, Inc.(RTSN)内部人交易:高管与董事近期交易
过去 18 个月,共有 6 位内部人为 Retension Pharmaceuticals, Inc.(RTSN)报告了 12 笔 Form 4 交易(最近一笔 2026-10-13)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-13 | BERENDT MICHAEL J | 董事 | 买入 | 4,026 | $0 |
| 2026-10-13 | BERGER FRANKLIN M | 董事 | 买入 | 12,517 | $0 |
| 2026-10-13 | Olds Donald | 董事 | 买入 | 5,637 | $0 |
| 2026-10-13 | Bisson Sabine | CHIEF OPERATING OFFICER | 买入 | 1,611 | $0 |
| 2026-10-13 | Keller Eric L. | CHIEF EXECUTIVE OFFICER | 买入 | 20,800 | $249,600 |
| 2026-10-13 | Sweetnam Paul | CHIEF SCIENTIFIC OFFICER | 买入 | 4,026 | $0 |
| 2026-10-13 | BERENDT MICHAEL J | 董事 | 买入 | 2,640 | $0 |
| 2026-10-13 | BERGER FRANKLIN M | 董事 | 买入 | 10,000 | $120,000 |
| 2026-10-13 | Bisson Sabine | CHIEF OPERATING OFFICER | 买入 | 2,504 | $0 |
| 2026-10-13 | Keller Eric L. | CHIEF EXECUTIVE OFFICER | 买入 | 9,662 | $0 |
| 2026-10-13 | Sweetnam Paul | CHIEF SCIENTIFIC OFFICER | 买入 | 2,640 | $0 |
| 2026-10-13 | Keller Eric L. | CHIEF EXECUTIVE OFFICER | 买入 | 31,368 | $0 |
来源:SEC Form 4 申报文件 · 截至 2026-10-13